Brick & Kyle, Associates - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 96 filers reported holding GW PHARMACEUTICALS PLC in Q1 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

Quarter-by-quarter ownership
Brick & Kyle, Associates ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2017$33,000
+50.0%
275
+37.5%
0.03%
+44.4%
Q4 2016$22,000
-18.5%
2000.0%0.02%
-18.2%
Q3 2016$27,000
+50.0%
2000.0%0.02%
+46.7%
Q2 2016$18,000
+28.6%
2000.0%0.02%
+25.0%
Q1 2016$14,0000.0%2000.0%0.01%0.0%
Q4 2015$14,000
-22.2%
2000.0%0.01%
-29.4%
Q3 2015$18,000
-28.0%
2000.0%0.02%
-19.0%
Q2 2015$25,000
+38.9%
2000.0%0.02%
+40.0%
Q1 2015$18,000
-10.0%
200
-33.3%
0.02%
-11.8%
Q4 2014$20,0003000.02%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2015
NameSharesValueWeighting ↓
Lamond Capital Partners LLC 134,230$9,085,0005.95%
VHCP Management, LLC 311,853$21,106,0005.81%
Iguana Healthcare Management, LLC 60,000$4,061,0001.96%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 366,187$24,784,0000.95%
ACUTA CAPITAL PARTNERS, LLC 20,000$1,354,0000.92%
United Asset Strategies, Inc. 14,278$966,0000.41%
PRUDENTIAL PLC 823,408$55,728,0000.24%
Rock Springs Capital Management LP 28,000$1,895,0000.22%
CLOUGH CAPITAL PARTNERS L P 84,600$5,726,0000.20%
Eventide Asset Management 25,000$1,692,0000.18%
View complete list of GW PHARMACEUTICALS PLC shareholders